Recombinant human soluble thrombomodulin as an anticoagulation therapy improves recurrent miscarriage and fetal growth restriction due to placental insufficiency ? The leading cause of preeclampsia
Recombinant human soluble thrombomodulin as an anticoagulation therapy improves recurrent miscarriage and fetal growth restriction due to placental insufficiency ? The leading cause of preeclampsia
复制标题
重组人可溶性血栓调节蛋白作为抗凝治疗可改善复发性流产和胎盘功能不全导致的胎儿生长受限？
DOI：
10.1016/j.placenta.2018.03.006
复制
发表时间：
2018
期刊：
影响因子：
3.8
通讯作者：
Ohmichi Masahide
中科院分区：
文献类型：
--
作者：
Sano Takumi;Terai Yoshito;Daimon Atsushi;Nunode Misa;Nagayasu Yoko;Okamoto Atsuko;Fujita Daisuke;Hayashi Masami;Ohmichi Masahide
